Shattuck Labs, Inc.: Form 10-Q for the period ended Sep 30, 2020
Filed with the SEC on Nov 13, 2020 and accepted by EDGAR at Nov 13, 2020, 16:10 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2020-09-30. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2020-07-01 to 2020-09-30 | $2.4m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Revenue | 9 months2020-01-01 to 2020-09-30 | $8.6m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Research and development | 3 months2020-07-01 to 2020-09-30 | $11.8m | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 9 months2020-01-01 to 2020-09-30 | $27.7m | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 3 months2020-07-01 to 2020-09-30 | −$11.8m | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months2020-01-01 to 2020-09-30 | −$24.9m | us-gaap:OperatingIncomeLoss |
| Net income | 3 months2020-07-01 to 2020-09-30 | −$11.8m | us-gaap:NetIncomeLoss |
| Net income | 9 months2020-01-01 to 2020-09-30 | −$24.6m | us-gaap:NetIncomeLoss |
| Operating cash flow | 9 months2020-01-01 to 2020-09-30 | −$19.6m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 9 months2020-01-01 to 2020-09-30 | $526.0k | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | At period end2020-09-30 | $128.6m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2020-09-30 | $142.3m | us-gaap:AssetsCurrent |
| Total assets | At period end2020-09-30 | $144.9m | us-gaap:Assets |
| Current liabilities | At period end2020-09-30 | $16.5m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2020-09-30 | $37.1m | us-gaap:Liabilities |
| Shareholders' equity | At period end2020-09-30 | −$58.4m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001680367-20-000012. Last ingested by Listed: Nov 5, 2026, 12:15 ET. Listed shows no prices and gives no investment advice.